| --- | --- | --- | --- | |----------------------------------------------|-------|-------|-------| | Click Here to Edit Title | | | | | | | | | | Third Quarter 2024 Earnings October 30, 2024 | | | | | | | | | Trusted Solutions, Improving Lives™ Cautionary Statement Click Here to Edit Title 2 Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 19 ...

For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Wendy Palacios Vice President FP&A and Investor Relations (847) 498-7070 IDEX REPORTS THIRD QUARTER RESULTS Third Quarter 2024 Highlights (All comparisons are against the third quarter of 2023 unless otherwise noted) • Sales of $798 million, up 1% overall and flat organically • Reported diluted EPS of $1.57, down 43%, and adjusted diluted EPS of $1.90, down 10% • Operating cash flow of $205 million, down 9%; and 172% of net income, up fro ...

IDEX Corporation's (IEX) third-quarter 2024 adjusted earnings of $1.90 per share surpassed the Zacks Consensus Estimate of $1.89. The bottom line decreased approximately 10.4% from the year-ago quarter's earnings of $2.12. However, it matched the upper band of the management's projected range of $1.85-$1.90 per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. IEX's Revenue Details IDEX's net sales of $798.2 million beat the Zacks Consensus Estimate of $791 million. The top li ...

For the quarter ended September 2024, Idex (IEX) reported revenue of $798.2 million, up 0.6% over the same period last year. EPS came in at $1.90, compared to $2.12 in the year-ago quarter. The reported revenue represents a surprise of +0.92% over the Zacks Consensus Estimate of $790.95 million. With the consensus EPS estimate being $1.89, the EPS surprise was +0.53%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Idex (IEX) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $2.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.53%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $2.04 per share when it actually produced earnings of $2.06, delivering a surprise of 0.98% ...

Oslo, Norway – October 29, 2024 – IDEX Biometrics has appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies.  Kristian has a background as CFO with Quantafuel ASA, recycling plastic ...

Oslo, Norway – 29 October 2024 - IDEX Biometrics ASA’s interim report for the third quarter is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Catharina Eklof, Chief Executive Officer, today at 09:00 CET. The webcast presentation is attached to this notice (link below), and can be viewed at the following link: https://idexbiometrics.video ...

IDEX Corporation (IEX) is scheduled to release third-quarter 2024 results on Oct. 29, after market close. The Zacks Consensus Estimate for earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 5.9%. The consensus estimate for revenues is pegged at $791 million, indicating a decline of 0.3% from the prior-year quarter's figure. The consensus estima ...

Group 1 - The private placement completed on 16 September 2024 raised total gross proceeds of NOK 70 million [1] - The share capital increase related to the Tranche 2 shares has been registered, resulting in a new share capital of NOK 120,812,483.10 divided into 805,416,554 shares, each with a nominal value of NOK 0.15 [2] - Tranche 2 shares will be delivered on a separate and non-tradable ISIN, pending the publication of an approved prospectus by the Norwegian Financial Supervisory Authority [2] Group 2 - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [3] - IDEX Biometrics partners with leading card manufacturers and technology companies to bring its solutions to market [3]

IDEX Biometrics ASA held an extraordinary general meeting on 9 October 2024. 112.2 million shares or 25.47% of the share capital was represented at the meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company's board of directors, including the approval of Tranche 2 of the private placement, the subsequent offering and the warrants issuance, all as announced on 17 September 2024. For further information contact: Marianne Bøe, Head of Investor Relations E-mail: ir@ide ...